Ligence Heart vs ClearRead CT
AI Verdict
Choose Ligence Heart if…
Choose Ligence Heart if your primary need is to automate and streamline the analysis and reporting of 2D transthoracic echocardiography. This platform is ideal for cardiology departments seeking to enhance diagnostic efficiency and accuracy for various heart conditions, including heart failure and valvular diseases, through AI-powered measurements and report generation.
View Ligence Heart →Choose ClearRead CT if…
Choose ClearRead CT if your focus is on improving the detection and characterization of pulmonary nodules and assessing coronary artery calcification from CT scans. This tool is best suited for radiology and pulmonology practices aiming to reduce reading times and increase diagnostic accuracy for lung and cardiac conditions using advanced vessel suppression and nodule tracking capabilities.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Ligence Heart | ClearRead CT |
|---|---|---|
| Pricing | Contact-for-pricing | Contact for pricing |
| Deployment | Cloud-based; on-premise; hybrid | On-premise (stand-alone server, virtual machine) and Cloud |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth Ligence Heart and ClearRead CT emphasize user-friendliness and seamless integration into existing clinical workflows. Ligence Heart is a web-based platform with an intuitive interface and automated report generation. ClearRead CT integrates directly into PACS without requiring additional viewers or logins, streamlining radiology workflows. Both aim to reduce manual effort and enhance efficiency for their respective users.
Clinical Value
ClearRead CTWhile both tools are FDA cleared and demonstrate strong clinical value, ClearRead CT provides more specific and quantifiable metrics for its clinical impact. It boasts a '29% reduction in missed actionable nodules' and 'Reduced Reading Time (up to 36%)'. Ligence Heart also claims improved accuracy and efficiency, with one study suggesting it 'outperformed humans in echocardiography', but ClearRead CT's direct, measurable improvements in nodule detection and reading time offer a more concrete demonstration of its clinical benefit.
Pricing & Value
TieBoth Ligence Heart and ClearRead CT employ a 'contact for pricing' model, which is typical for specialized enterprise healthcare AI solutions. Neither provides transparent pricing details in the structured facts or publicly available information. Therefore, a direct comparison of their pricing or value proposition based on cost is not possible without direct vendor engagement.
Enterprise Readiness
Ligence HeartLigence Heart explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, along with FDA clearance, CE mark, and ISO certifications. It also offers flexible deployment options (cloud, on-premise, hybrid) and integration with PACS, EHR, and RIS. While ClearRead CT is FDA cleared, ISO27001 certified, and operates with institutions like the VA, its BAA and HIPAA compliance are listed as 'likely, contact vendor for details' in the provided facts, making Ligence Heart's stated readiness more definitive.
Innovation
ClearRead CTClearRead CT stands out with its 'Patented Vessel Suppression (Clear Visual Intelligence)' technology, which uniquely removes vessels and machine noise to provide an unimpaired view for nodule detection. It also utilizes a 'simulation engine to generate challenging cases to train the algorithm'. While Ligence Heart offers comprehensive AI-powered automation for echocardiography analysis, the explicit mention of a patented technology and advanced training methodology suggests a more distinct and recognized innovative approach in ClearRead CT's offering.
Support & Docs
ClearRead CTClearRead CT offers a more comprehensive suite of support resources, including a dedicated Customer Success Hotline, email support, a support ticket system, and a wider range of detailed documentation such as User Manuals, Administrator Manuals, DICOM Conformance Statements, and FAQs. Ligence Heart provides Instructions for Use, Software Installation Manuals, and email support, but ClearRead CT's offerings appear more extensive and structured for enterprise-level support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Ligence Heart | ClearRead CT |
|---|---|---|
| Tool Name | Ligence Heart | ClearRead CT |
| Company | Ligence | RIVERAIN TECHNOLOGIES |
| Description | Ligence Heart is an AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. | ClearRead CT is an FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology. |
| Primary Modality | 2D Transthoracic Echocardiography | CT Scans |
| Key Features (Cardiology) | Automated recognition of echocardiography imaging data, Automated view classification and heart phase prediction, Automated calculation of measurements and report generation, Area, Distance, Doppler, and Volume quantification, Disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases), Automated strain, Spectral and Tissue Doppler measurements | Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs) |
| Key Features (Other) | Transfer of echocardiography images (PHI removed) from hospital PACS, Integration with existing systems (PACS, EHR, RIS) | Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression (Clear Visual Intelligence), Nodule Characterization and Measurement (volume, diameter, location, type, depth), Automated Nodule Tracking and Comparison to Prior Exams, Reduced Reading Time (up to 36%), Improved Detection Accuracy (29% reduction in missed actionable nodules), Seamless PACS Integration / Vendor-neutral processing |
Videos
Demos, reviews, and walkthroughs featuring Ligence Heart and ClearRead CT.